Off-Label Drug Use in China: Management Guideline 2021 Explained
Off-label drug use is sometimes a reasonable clinical need but carries safety and legal risk. China's 2021 management guideline (Peking Union + Lanzhou University) sets the first standardized, governed procedure for it.
Updated 2022-09-23 · Reviewed for clinical accuracy
What is off-label use?
The first national management guideline
Core principles
What it means for patients
In short
“Off-Label Drug Use in China: Management Guideline 2021 Explained” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.
Key facts
Published in English
Reading time shown on every guide
Links to related specialists and hospitals
Reviewed for clinical accuracy
Frequently asked questions
Is this guide medical advice?
No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.
Can I get the guide in Chinese?
The guides are published in English; interpretation and translation are arranged as a separate service.
How do I find a specialist for this?
Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.
When general anaesthesia is recommended for children's dental care, the fasting and assessment rules, what happens on the day, and the…
4 min readUpdated 2026-10-03
We use strictly necessary cookies to run this website. Optional analytics cookies help us
understand how the site is used, and load only if you agree. See our
Cookie Policy.